CYPH — CYPHERPUNK TECHNOLOGIES INC.

Nasdaq · Health Care · Pharmaceuticals · CIK 1509745 ·
Last close
$1.16
Market Cap
$123.50M
52W High
$1.40
52W Low
$0.50
ADV30
4,003,331
Next earnings
2026-08-13
Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -4,817,000 -77,166,000 87,378,000 6,689,000 3,003,000
Dec 2025 0 -5,260,000 40,203,000 163,182,000 14,035,000 9,676,000
Sep 2025 0 -3,222,000 -3,303,000 11,399,000 9,686,000 8,704,000
Jun 2025 0 -12,353,000 -16,643,000 20,042,000 18,130,000 14,325,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-43,902,000
Investing CF
$0
Financing CF
$107,649,000
CapEx
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-1.22
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-462,549,000
Inventory
Receivables
$148,006,000
ST Investments
EBIT TTM
$10,101,000
Pretax Income TTM
$10,077,000
Interest Exp TTM
$24,000
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -36,697,000 4,822,000 163,182,000 9,676,000 -43,902,000
Dec 2024 0 -70,057,000 -67,555,000 49,124,000 14,076,000 -60,299,000
Dec 2023 0 -85,940,000 -81,414,000 72,825,000 12,684,000 -43,753,000
Dec 2022 0 -54,712,000 -54,596,000 70,353,000 11,487,000 -49,044,000

Peers — same industry

TickerNameMarket CapLastDaily %
PLYX Polaryx Therapeutics, Inc. $122.15M $2.58
INDP Indaptus Therapeutics, Inc. $125.70M $1.11
QTTB Q32 Bio Inc. $120.22M $7.09
HSTC HST Global, Inc. $117.39M $0.83
VTVT vTv Therapeutics Inc. $130.61M $33.16

News headlines (Yahoo Finance, 1h cache)

Zcash Outpaces Bitcoin Gains as Key Development Team Raises $25 Million
2026-03-09 20:19 · Yahoo
David Beckham’s Prenetics Ditches Bitcoin Strategy as Santa Rally Fails
2025-12-31 16:57 · Yahoo
Winklevoss-backed Cypherpunk buys $28 million of zcash, now owns 1.7% of supply
2025-12-31 09:50 · Yahoo
Is Zcash the Next Corporate Treasury Play? Cypherpunk Now Holds Nearly 2%
2025-12-30 23:18 · Yahoo
Surveillance is a "Dangerous Experiment" - Zcash Founder Zooko Wilcox on Why Privacy is Actually the Historical Norm
2025-12-10 20:51 · Yahoo
Winklevoss Twins Double Down on Zcash — Hire ZEC Founder Zooko Wilcox as Advisor
2025-12-10 11:02 · Yahoo
Cypherpunk Technologies (CYPH): How a Radical Crypto Pivot Is Shaping Its Current Valuation
2025-11-14 15:16 · Yahoo
Cypherpunk Stock Soars on Zcash Rebrand. Should You Buy the Crypto Penny Stock Here?
2025-11-14 14:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.